Dr. Concepcion is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4124 Sneed Road
Nashville, TN 37215Phone+1 615-504-6919
Summary
Education & Training
- Vanderbilt University Medical CenterResidency, Urology, 1986 - 1990
- Vanderbilt University Medical CenterResidency, Surgery, 1984 - 1986
- The University of Toledo College of MedicineClass of 1984
- The University of Toledo College of MedicineB.S., Biology, Magna Cum Laude, 1979
Certifications & Licensure
- TN State Medical License 2018 - 2025
- American Board of Urology Urology
Awards, Honors, & Recognition
- Past President, Founding Board Member Large Urology Group Practice Association, 2008-2012
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012
- The University of Toledo Honors Scholarship 1975
- Join now to see all
Clinical Trials
- Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T Start of enrollment: 2012 Oct 01
- Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2012 Jan 01
- PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study Start of enrollment: 2014 Sep 01
Publications & Presentations
PubMed
- Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.Neal D Shore, Christian Gratzke, Susan Feyerabend, Patrick Werbrouck, Joan Carles
The Oncologist. 2024-07-05 - 1 citationsDevelopment and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer.Neal D Shore, Dmitry M Polikarpov, Christopher M Pieczonka, R Jonathan Henderson, James L Bailen
Urologic Oncology. 2023-11-01 - 1 citationsCorrection: Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial.David F Penson, Andrew J Armstrong, Raoul S Concepcion, Neeraj Agarwal, Carl A Olsson
Prostate Cancer and Prostatic Diseases. 2022-09-01
Journal Articles
- The Effect of Local Antibiogram-based Augmented Antibiotic Prophylaxsis on Infection-related Complications Following Prostate BiopsyConcepcion RS, Schaeffer, EM, Shore ND, et al, Reviews in Urology, 3/2019
- Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjectsDaniel Saltzstein, Neal D. Shore, Judd W. Moul, Franklin Chu, Raoul Concepcion, Stephan de la Motte, John A. McLane, Stuart Atkinson, Alex Yang, E. David Crawford, Therapeutic Advanced in Urology, 11/22/2017
- Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volumeFowke JH, Phillips S, Koyama T, Byerly S, Concepcion R, Motley SS, Clark PE, BJU Int., 1/1/2013
- Join now to see all
Abstracts/Posters
- Late Administration of Luteinizing Hormone-Releasing Hormone (LHRH) Agonists and the Impact on Testosterone Suppression in the Real-World Management of Prostate CancerConcepcion RS, Crawford ED, Atkinson S, et al, ASCO GU, San Francisco CA, 2/8/2019
- Impact of enzalutamide vs bicalutamide on health related quality of life (HRQofL) of patients with CRPC: STRIVE studyRS Concepcion, AJ Armstrong, L Karsh, et al, Genitourinary Cancer Symposium, San Francisco CA, 2/8/2018
- Head to Head PK and PD Comparison of Subcutaneous vs IntramuscularMoul J, Concepcion R, Atkinson S, Society of Government Service Urologists, San Diego CA, 1/23/2017
- Join now to see all
Lectures
- The Evolving Prostate Cancer Landscape: PCEC LectureNashville TN - 10/10/2019
- Community Urology Perspective on Germline Testing for Prostate CancerPhiladelphia Prostate Cancer Consensus Conference 2019 - 10/5/2019
- Current Challenges in the Management of Advanced Prostate CancerFDUS 2019, Colorado Springs CO - 8/5/2019
- Join now to see all
Press Mentions
- U.S. Urology Partners Names Healthcare Visionary Raoul S. Concepcion, M.D., as Chief Science OfficerJune 22nd, 2021
- SynDevRx Assembles Prostate Cancer Medical Advisory Board to Oversee Drug Candidate That Targets Link Between Obesity and Prostate CancerJanuary 25th, 2021
- VerdePharmHealth Strengthens Board of Directors and Advisory PanelFebruary 26th, 2020
- Join now to see all
Committees
- Prostate Cancer Panel, SUO - CTC 2019 - Present
Professional Memberships
- Member
- Member
- Society of Urologic OncologyMember
- CUSP Research ConsortiumCo-founder
Industry Relationships
- Consultant, Invitae2018 - Present
- Consultant, Cellay2016 - Present
- Consultant, Integra ConnectChief Urologic Clinical Advisor2016 - Present
- National Speaker, Janssen Pharmaceuticals2013 - Present
- National Speaker, Astellas, Astellas2012 - Present
- Consultant, Dendreon2011 - Present
- Consultant, Merck2019 - 2019
- Consultant, Sun Pharma2018 - 2019
- Consultant, Clovis2018 - 2019
- National Speaker, Pfizer2017 - 2019
- National Speaker, Amgen2010 - 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: